Quotient Technology Inc Stock News

Retail marketing firm Neptune Retail Solutions will acquire Coupons.com-parent Quotient Technology for $430 million in cash, the companies said on Tuesday.

Quotient is planning to go private for roughly $400 million. The deal is expected to close by the end of 2023.

Every time I write about meme stocks to buy I preface the article with a variation of the same caveat: Meme stocks may have started as high-risk jokes, but over time, meme stock strategies have become

Quotient Technology Inc. (NYSE:QUOT ) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET Company Participants Matthew Krepsik - Chief Executive Officer Yuneeb Khan - Chief Financial Officer Confe

The company might be considering selling itself.

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the Euro

Penny stocks to buy according to analysts in 2023 The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 952% appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto

U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session. WW International, Inc. (NASDAQ: WW) shares jumped 29

Quotient's sales are shrinking as demand dries up for digital promotions. Management is focused on cutting costs today.

Penny stocks to buy according to analysts in 2023 The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 952% appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto

Quotient Technology is undoubtedly one of the companies that has been able to get the most out of the returns in relation to the transformation of the advertising culture. In my view, the fact that Qu

Quotient Technology Inc. (NYSE:QUOT ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Marc Griffin - Senior Vice President of Investor Relations Matt Krepsik - Chief

Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 212.8% to close at $12.51 on Wednesday after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimac

The digital marketing specialist refinanced a massive convertible debt load and gained market share in a difficult market environment.

Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares jumped 219% to $12.80 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $